GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aurora Cannabis Inc (TSX:ACB) » Definitions » EV-to-EBITDA

Aurora Cannabis (TSX:ACB) EV-to-EBITDA : -5.71 (As of Apr. 29, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Aurora Cannabis EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Aurora Cannabis's enterprise value is C$456.0 Mil. Aurora Cannabis's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was C$-79.8 Mil. Therefore, Aurora Cannabis's EV-to-EBITDA for today is -5.71.

The historical rank and industry rank for Aurora Cannabis's EV-to-EBITDA or its related term are showing as below:

TSX:ACB' s EV-to-EBITDA Range Over the Past 10 Years
Min: -951.75   Med: -2.55   Max: 411.47
Current: -5.71

During the past 13 years, the highest EV-to-EBITDA of Aurora Cannabis was 411.47. The lowest was -951.75. And the median was -2.55.

TSX:ACB's EV-to-EBITDA is ranked worse than
100% of 708 companies
in the Drug Manufacturers industry
Industry Median: 14.22 vs TSX:ACB: -5.71

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-04-29), Aurora Cannabis's stock price is C$9.19. Aurora Cannabis's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was C$-3.900. Therefore, Aurora Cannabis's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Aurora Cannabis EV-to-EBITDA Historical Data

The historical data trend for Aurora Cannabis's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aurora Cannabis EV-to-EBITDA Chart

Aurora Cannabis Annual Data
Trend Jun12 Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -45.75 52.84 -53.07 -0.72 -4.11

Aurora Cannabis Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.26 -0.47 -1.73 -3.40 -3.83

Competitive Comparison of Aurora Cannabis's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Aurora Cannabis's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aurora Cannabis's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aurora Cannabis's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Aurora Cannabis's EV-to-EBITDA falls into.



Aurora Cannabis EV-to-EBITDA Calculation

Aurora Cannabis's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=456.006/-79.807
=-5.71

Aurora Cannabis's current Enterprise Value is C$456.0 Mil.
Aurora Cannabis's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-79.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aurora Cannabis  (TSX:ACB) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Aurora Cannabis's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=9.19/-3.900
=At Loss

Aurora Cannabis's share price for today is C$9.19.
Aurora Cannabis's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-3.900.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Aurora Cannabis EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Aurora Cannabis's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Aurora Cannabis (TSX:ACB) Business Description

Traded in Other Exchanges
Address
3498 63 Avenue, Leduc, AB, CAN, T9E 0G8
Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements.